| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
FORMT
|
1.51 | 1.6B | — | 0.73 | 3.79 | -3.5% | 44.3% | 59 | 34 | 4.32 | +94.7% | 51 | 0.08 |
|
BMSCH
|
10.46 | 1.0B | — | 0.82 | 11.76 | -0.4% | 33.9% | 55 | 33 | 18.39 | +38.6% | 40 | 0.42 |
|
IMASM
|
2.26 | 2.1B | — | 0.77 | 11.03 | 13.2% | 46.2% | 54 | 32 | 3.30 | +29.6% | 68 | 0.04 |
|
MAKTK
|
10.29 | 2.1B | — | 1.10 | 6.78 | 4.4% | 44.8% | 52 | 26 | 13.58 | +18.8% | 60 | 0.10 |
|
KLMSN
|
28.00 | 2.2B | — | 0.56 | 23.80 | 0.5% | 20.3% | 50 | 29 | 48.09 | +36.6% | 25 | 1.01 |
|
SNICA
|
3.13 | 1.9B | — | 0.38 | — | 1.2% | 38.9% | 49 | 27 | 5.64 | +40.9% | 49 | 0.20 |
|
MAKIM
|
15.19 | 1.7B | — | 1.38 | 13.99 | 3.5% | 38.0% | 47 | 32 | 17.67 | +9.1% | 63 | 0.39 |
|
SAFKR
|
17.07 | 3.4B | 23.69 | 2.71 | 11.77 | 19.3% | 46.1% | 46 | 26 | 13.01 | -17.8% | 94 | 0.06 |
|
GEREL
|
36.88 | 13.7B | 36.49 | 3.83 | 17.21 | 4.2% | 42.2% | 42 | 26 | 32.12 | -8.2% | 63 | 0.39 |
|
HKTM
|
13.10 | 1.4B | — | 1.31 | 8.92 | 4.2% | 40.8% | 42 | 35 | 18.13 | +19.5% | 42 | 0.40 |
|
PRKAB
|
30.58 | 6.6B | — | 7.59 | 6.40 | 23.5% | 44.8% | 40 | 34 | 23.70 | -13.3% | 58 | 0.06 |
|
ULUSE
|
235.00 | 18.8B | 24.03 | 19.19 | 28.59 | 19.9% | 42.2% | 38 | 20 | 146.75 | -25.2% | 49 | 1.94 |
|
ALVES
|
1.31 | 21.0B | 100.00 | 7.72 | 12.95 | 27.1% | 41.2% | 29 | 29 | 0.52 | -43.5% | 56 | 1.27 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.